(Q44782991)

6 December 2017

title

Mycophenolate mofetil combined with prednisone for diffuse proliferative lupus nephritis: a histopathological study (English)

1 reference

6 December 2017

1 reference

Lei Ding

1

1 reference

6 December 2017

Minghui Zhao

2

1 reference

6 December 2017

Wanzhong Zou

3

1 reference

6 December 2017

Yuchun Liu

4

1 reference

6 December 2017

Haiyan Wang

5

1 reference

6 December 2017

publication date

1 January 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

13

1 reference

6 December 2017

issue

2

1 reference

6 December 2017

page(s)

113-118

1 reference

Mycophenolate mofetil for the treatment of systemic lupus erythematosus: an open pilot trial.

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU513OA

Cytokine network and resident renal cells in glomerular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU513OA

Lupus nephritis: correlation of interstitial cells with glomerular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU513OA

Vascular cell adhesion molecule-1 (VCAM-1) expression in murine lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU513OA

Cytokines and adhesion molecules in renal vasculitis and lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU513OA

Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU513OA

Tubulointerstitial damage in glomerular diseases: Its role in the progression of renal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU513OA

10.1191/0961203304LU513OA

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference